Two vitamin C manufacturers based in China are reportedly arguing in a New York court that their government is responsible for their price-fixing. A class-action suit has been filed in US District Court in New York accusing two vitamin C companies of raising prices between December 2001 and June 2006. The media are reporting that the defendants will use the foreign sovereign compulsion doctrine defense, a rare argument that claims companies that break US law are protected if their own governments coerced the companies into that legal violation. The defense is seldom successful, say experts. Jury selection was scheduled for Monday.
Featured News
Former DOJ Antitrust Lawyer Returns to Sullivan & Cromwell
Jul 27, 2026 by
CPI
Trip.com Accepts $765 Million Antitrust Penalty as China Concludes Monopoly Investigation
Jul 27, 2026 by
CPI
Google Seeks to Exclude EU DMA Decision From Evidence in UK Shopping Damages Trial
Jul 27, 2026 by
CPI
Judge Allows Beef Price-Fixing Class Action to Move Toward Trial
Jul 27, 2026 by
CPI
Japanese Banks Combine Ship Finance Operations to Form $12.8B Maritime Lending Platform
Jul 27, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes